Home/ Stocks/ VRAX

Virax Biolabs Group Limited Ordinary Shares

VRAX XNAS

$0.20 +0.04 (+23.63%) ▲ 15-min delayed

Open

$0.25

High

$0.28

Low

$0.20

Volume

228.82M

Market Cap

$1.21M

About Virax Biolabs Group Limited Ordinary Shares

Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.

Employees: 19 Website →

TickerDaily Coverage

Why Is Virax Biolabs Group Limited Ordinary Shares (VRAX) Stock Up 54.9% Today?

Penny Stocks Marcus Rivera · 5h ago

Virax Biolabs Group Limited (VRAX) stock ripped 54.9% higher on Tuesday, March 31, 2026, after...

View All Coverage →

Get VRAX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Virax Biolabs Group Limited Ordinary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.